How Catalent Biologics Speeds Up Cell Line Development
Source: Berkeley Lights
Catalent Biologics, part of Catalent Inc., takes biologics from cell line development through to finished product supply using their proprietary GPEx® Cell Line Development technology, which creates stable, high-yielding mammalian cell lines for even the most difficult to express proteins. See how they were able to speed up their process and get the best clones by investing in the Beacon® optofluidic system from Berkeley Lights.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more